5750
L.-Y. Chen et al. / Tetrahedron Letters 50 (2009) 5748–5750
2. (a) Heck, R. F. Accounts Chem. Res. 1979, 12, 146–151; (b) Link, J. T. Org. React.
tert-BuOK
- tert-BuOH
2002, 60, 157–534; (c) Laschat, S.; Narjes, F.; Overman, L. E. Tetrahedron 1994,
50, 347–358; (d) Grigg, R.; Fretwell, P.; Meerholtz, C.; Sridharan, V. Tetrahedron
1994, 50, 359–370; (e) Hudlicky, T.; Olivo, H. F. J. Amer. Chem. Soc. 1992, 114,
9694–9696; (f) Sundberg, R. J.; Cherney, R. J. J. Org. Chem. 1990, 55, 6028–6037.
3. (a) Mealy, M. J.; Bailey, W. F. J. Organomet. Chem. 2002, 646, 59–67; (b) Kamyar,
A. J. Chem. Soc., Perkin Trans. 1 1999, 15, 2025–2046; (c) Coldham, I. J. Chem. Soc.,
Perkin Trans. 1 1998, 7, 1343–1364.
tert-BuOK
H
H
O
O
O
O
3
K
4. (a) Malacria, M. Chem. Rev. 1996, 96, 289–306. and literatures cited therein; (b)
Majumdar, K. C.; Basu, P. K.; Mukhopadhyay, P. P. Tetrahedron 2004, 60, 6239–
6278; (c) Majumdar, K. C.; Ray, K.; Debnath, P.; Maji, P. K.; Kundu, N.
Tetrahedron Lett. 2008, 49, 5597–5600.
5. Ichikawa, J.; Miyazaki, H.; Sakoda, K.; Wada, Y. J. Fluorine Chem. 2004, 125, 585–
593.
tert-BuOH
O
O
O
O
K
6. (a) Sono, M.; Hashimoto, A.; Nakashima, K.; Tori, M. Tetrahedron Lett. 2000, 41,
5115–5118; (b) Sono, M.; Nakashiba, Y.; Nakashima, K.; Tori, M. J. Org. Chem.
2000, 65, 3099–3106.
7. (a) Wataha, J. C.; Hanks, C. T. J. Oral Rehabil. 1996, 23, 309–320; (b) Liu, T. Z.;
Lee, S. D.; Bhatnagar, R. S. Toxicol. Lett. 1979, 4, 469–473; (c) Moore, W.; Hysell,
D.; Hall, L.; Campbell, K.; Stara, J. Environ. Health Persp. 1975, 10, 63–71; (d)
Nyarko, E.; Hara, T.; Grab, D. J.; Habib, A.; Kim, Y.; Nikolskaia, O.; Fukuma, T.;
Tabata, M. Chem. Biol. Interact. 2004, 148, 19–25.
+
tert-BuOK
O
O
4
Scheme 2. The proposed mechanism of intramolecular carbanion-olefin cyclization
of 3.
8. Payard, M.; Tronche, P.; Bastide, J.; Bastide, P.; Chavernac, G. European J. Med.
Chem. 1981, 16, 453–470.
9. The procedure for the preparation of compounds 3a–k, and 4a–k together with
their physical and spectral data which were obtained are given in
Supplementary data.
R1
R2
CHO
OH
R1
R2
R4
i, ii, iii
O
10. 1-(2-Methoxy-6-vinylphenoxy)-2-phenylhexan-2-ol (2.22 g, 68%) was obtained as
R3
1a-e
R3
O
colorless liquid, Rf = 0.48 (ethyl acetate/n-hexane = 1:7), IR (neat)
3062, 3026, 2955, 2869, 1576, 1473, 1299, 1266, 1212, 1069, 1028, 909, 795, 747,
702 cmꢀ1 1H NMR (CDCl3, 200 MHz) d 0.83 (t, J = 7.0 Hz, 3H, (CH2)2CH2CH3),
mmax: 3497,
4a-i
;
Scheme 3. Synthesis of 2-aroyl-3,4-dihydro-2H-benzopyrans (4ai) from salicyli-
caldehydes (1a–e) in a three-step one pot reaction. Reagents and conditions: (i) (a)
MTPPB (1.2 equiv), tert-BuOK (2.3 equiv), THF, rt, 1 h; (ii) (b) 2-bromoacetophenone
(2a) (1.1 equiv), 2-bromo-40-methoxyacetophenone (2b) (1.1 equiv), 2-bromo-40-
chloro-acetophenone (2c) (1.1 equiv), reflux, 1 h; (iii) tert-BuOK (1.2 equiv), THF,
reflux, 30 min.
1.00–1.45 (m, 4H, CH2(CH2)2CH3), 1.75–2.04 (m, 2H, CH2(CH2)2CH3), 3.79 (s, 3H,
OCH3), 4.05 (d, J = 9.6 Hz, 1H, OCHaHbC), 4.05 (br s, 1H, OH), 4.14 (d, J = 9.4 Hz, 1H,
OCHaHbC), 5.23 (dd, J = 11.2, 1.2 Hz, 1H, ArCH@CHaHb), 5.66 (dd, J = 17.8, 1.2 Hz,
1H, ArCH@CHaHb), 6.74 (dd, J = 8.0, 1.6 Hz, 1H, ArH), 6.82 (dd, J = 17.8, 11.2 Hz,
1H, ArCH@CH2), 6.96 (t, J = 8.0 Hz, 1H, ArH), 7.05 (dd, J = 8.0, 1.6 Hz, 1H, ArH),
7.18–7.26 (m, 1H, ArH), 7.30–7.38 (m, 2H, ArH), 7.49–7.54 (m, 2H, ArH); 13C-
NMR (CDCl3, 50 MHz) d 13.9, 23.0, 25.2, 38.6, 55.7, 76.3, 81.4, 111.3, 115.5, 118.1,
124.1, 125.5, 126.5, 127.9, 131.1, 131.9, 143.8, 145.6, 152.1; EI-MS (70 eV) m/z
(rel intensity, %) 308 (M+ꢀH2O, 3), 251 (19), 164 (100), 150 (98), 135 (28), 121
(29), 107 (23), 91 (29).
one-pot reaction could not improve the total yields compared to
that of the two-step reaction, it provides a unique and concise
route to handle and leads to less workup procedures. Besides, the
reduction of environmental pollutants is also advantage. Thus,
we have provided a concise and green chemistry for the synthesis
of title compounds either in two steps or in a one-pot reaction in
good total yields, respectively. Further applications and the devel-
opment of this type of reaction for other heterocyclic compounds
are currently in progress in our laboratory.
11. General procedure for the preparation of 2-aroyl-3,4-dihydro-2H-benzopyranes
(4a–k) from salicylaldehydes (1a–h) in one pot: under nitrogen, a suspension of
MTPPB (4.29 g, 12 mmol) in anhydrous THF (15 mL) was treated with potassium
tert-butoxide (1.35 g, 12 mmol) in portions. After stirring for 10 min at room
temperature, to the resultant reaction mixture was added a mixture of 2-
hydroxybenzaldehydes (1a–h) (10 mmol) and potassium tert-butoxide (1.23 g,
11 mmol) in THF (15 mL). The given mixture stirred at room temperature for 1 h
was heated to the reflux, and then was added
a solution of 2-
bromoacetophenones (2a–c) (33 mmol) in THF (15 mL) in drops. To the
resultant mixture continually stirred under reflux for 1 h was added another
portion of potassium tert-butoxide (1.35 g, 12 mmol). The reaction mixture was
kept at reflux for 0.5–1 h until the desired 4 did not increase apparently as
denoted by the TLC analysis. Finally, the reaction was quenched with saturated
NH4Clsolution. Most of the THF was removed in vacuo, and the resultant mixture
was extracted with EtOAc (20 mL ꢁ 4). The organic layers were combined,
washed with brine, and dried with anhydrous MgSO4. After filtration, the filtrate
was concentrated in vacuo. The residue was purified by silica gel column
chromatography (ethyl acetate/n-hexane = 1:10) to give pure 4a (1.11 g, 47%),
4b (1.77 g, 66%), 4c (1.92 g, 64%), 4d (2.03 g, 64%), 4e (1.69 g, 62%), 4f (2.05 g,
67%), 4g (1.79 g, 58%), 4h (1.88 g, 62%), 4i (1.21 g, 41%), 4j (1.30 g, 48%), and 4k
(0.74 g, 33%), respectively. Selected physical and spectra data of 4b: it was
Acknowledgment
We are grateful to NSC (NSC 97-2113-M-037-001-MY2),
Taiwan, for financial support.
Supplementary data
obtained as
hexane = 1:4); IR (KBr)
1217, 1091, 991, 903, 694 cmꢀ1
a
colorless crystal, mp 91–93 °C; Rf 0.49 (ethyl acetate/n-
max: 3062, 2931, 2836, 1695 (C@O), 1579, 1478, 1339,
1H NMR (400 MHz, CDCl3) d 2.18–2.27 (m, 1H,
Supplementary data associated with this article can be found, in
m
;
Ha-3), 2.29–2.36 (m, 1H, Hb-3), 2.69–2.76 (m, 1H, Ha-4), 2.79–2.87 (m, 1H, Hb-
4), 5.56 (dd, J = 6.8, 4.0 Hz, 1H, H-2), 6.65 (dd, J = 7.6, 1.2 Hz, 1H, ArH), 6.73, (dd,
J = 7.6, 1.2 Hz, 1H, ArH), 6.81(t, J = 7.6 Hz, 1H, ArH), 7.43–7.47 (m, 2H, ArH), 7.56
(tt, J = 7.6, 1.2 Hz, 1H, ArH), 8.01–8.03 (m, 2H, ArH); 13C NMR (100 MHz, CDCl3) d
22.8, 24.2, 55.9, 77.1, 109.7, 120.1, 121.3, 122.1, 128.6, 128.8, 133.4, 134.5, 143.4,
148.3, 196.9; EIMS (70 eV) m/z (rel intensity, %) 268 (M+, 26), 163 (100), 105 (31);
Anal. Calcd for C17H16O3: C, 76.10; H, 6.01. Found: C, 76.11; H, 5.76.
References and notes
1. (a) Harding, K. E.; Tiner, T. H.. In Comprehensive Organic Synthesis; Semmelhack,
M. F., Ed.; Pergamon Press: Oxford, 1991; Vol. 4, p 363; (b) Frederickson, M.;
Grigg, R. Org. Prep. Proced. Int. 1997, 29, 33–62. and 63–116; (c) Ali Dondas, H.;
Grigg, R.; Hadjisoteriou, M.; Markandu, J.; Kennewell, P.; Thornton-Pett, M.
Tetrahedron 2001, 57, 1119–1128.